|
US4937190A
(en)
|
1987-10-15 |
1990-06-26 |
Wisconsin Alumni Research Foundation |
Translation enhancer
|
|
US6133029A
(en)
|
1988-03-21 |
2000-10-17 |
Chiron Corporation |
Replication defective viral vectors for infecting human cells
|
|
US5997859A
(en)
|
1988-03-21 |
1999-12-07 |
Chiron Corporation |
Method for treating a metastatic carcinoma using a conditionally lethal gene
|
|
US5716826A
(en)
|
1988-03-21 |
1998-02-10 |
Chiron Viagene, Inc. |
Recombinant retroviruses
|
|
DE68921034D1
(de)
|
1988-09-27 |
1995-03-23 |
Dana Farber Cancer Inst Inc |
Vektor, der ein replikationskompetentes HIV-I-Provirus und ein heterologes Gen enthält.
|
|
US5674486A
(en)
|
1991-06-25 |
1997-10-07 |
San Diego Regional Cancer Center |
Cancer immunotherapy with carrier cells
|
|
DK0598029T3
(da)
|
1991-08-07 |
2002-05-27 |
W French Anderson |
Retrovirale vektorer indeholdende interne ribosome indgangssteder
|
|
WO1993010218A1
(en)
|
1991-11-14 |
1993-05-27 |
The United States Government As Represented By The Secretary Of The Department Of Health And Human Services |
Vectors including foreign genes and negative selective markers
|
|
CA2148934C
(en)
|
1992-11-09 |
2005-08-02 |
French W. Anderson |
Targetable vector particles
|
|
US5770428A
(en)
|
1993-02-17 |
1998-06-23 |
Wisconsin Alumni Research Foundation |
Chimeric retrovial expression vectors and particles containing a simple retroviral long terminal repeat, BLV or HIV coding regions and cis-acting regulatory sequences, and an RNA translational enhancer with internal ribsome entry site
|
|
AU680508B2
(en)
|
1993-04-06 |
1997-07-31 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Gibbon ape leukemia virus-based retroviral vectors
|
|
FR2716459B1
(fr)
|
1994-02-22 |
1996-05-10 |
Univ Paris Curie |
Système hôte-vecteur utilisable en thérapie génique.
|
|
US5585096A
(en)
|
1994-06-23 |
1996-12-17 |
Georgetown University |
Replication-competent herpes simplex virus mediates destruction of neoplastic cells
|
|
JP4046349B2
(ja)
|
1994-11-07 |
2008-02-13 |
ヒューマン ジノーム サイエンシーズ， インコーポレイテッド |
腫瘍壊死因子−γ
|
|
US20030157070A1
(en)
|
1994-12-30 |
2003-08-21 |
Jolly Douglas J. |
High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations
|
|
US6117681A
(en)
|
1995-03-29 |
2000-09-12 |
Bavarian Nordic Research Inst. A/S |
Pseudotyped retroviral particles
|
|
AU2363695A
(en)
|
1995-04-27 |
1996-11-18 |
Human Genome Sciences, Inc. |
Human tumor necrosis factor receptors
|
|
US20030026789A1
(en)
|
1995-05-03 |
2003-02-06 |
Richard J. Gregory |
Gene therapy using replication competent targeted adenoviral vectors
|
|
GB9604354D0
(en)
|
1996-02-29 |
1996-05-01 |
Isis Innovation |
Targeting adapters
|
|
WO1997033904A1
(en)
|
1996-03-12 |
1997-09-18 |
Human Genome Sciences, Inc. |
Death domain containing receptors
|
|
WO1997033899A1
(en)
|
1996-03-14 |
1997-09-18 |
Human Genome Sciences, Inc. |
Apoptosis inducing molecule i
|
|
WO1998007880A1
(en)
|
1996-08-16 |
1998-02-26 |
Human Genome Sciences, Inc. |
Human endokine alpha
|
|
DK0920505T3
(da)
|
1996-08-16 |
2008-09-08 |
Schering Corp |
Pattedyrcelleoverfladeantigener og tilhörende reagenser
|
|
US6025192A
(en)
|
1996-09-20 |
2000-02-15 |
Cold Spring Harbor Laboratory |
Modified retroviral vectors
|
|
NZ334309A
(en)
|
1996-10-25 |
2000-08-25 |
Human Genome Sciences Inc |
Neutrokine alpha protein, a member of the TNF family, and its use in treating and/or detecting immune disorders
|
|
EP0990031B1
(en)
|
1997-01-14 |
2006-03-29 |
Human Genome Sciences, Inc. |
Tumor necrosis factor receptor 5
|
|
ATE362982T1
(de)
|
1997-01-28 |
2007-06-15 |
Human Genome Sciences Inc |
ßDEATH-DOMAINß-ENTHALTENDER REZEPTOR 4 (DR4), EIN MITGLIED DER TNF-REZEPTOR SUPERFAMILIE, WELCHER AN TRAIL (APO-2L) BINDET
|
|
US6248721B1
(en)
|
1997-04-09 |
2001-06-19 |
Lung-Ji Chang |
Method of using mouse model for evaluation of HIV vaccines
|
|
US6207455B1
(en)
|
1997-05-01 |
2001-03-27 |
Lung-Ji Chang |
Lentiviral vectors
|
|
US6214580B1
(en)
|
1997-05-30 |
2001-04-10 |
Human Genome Sciences, Inc. |
Human tumor necrosis factor receptor tr10
|
|
CA2295991A1
(en)
|
1997-06-11 |
1998-12-17 |
Human Genome Sciences, Inc. |
Human tumor necrosis factor receptor tr9
|
|
EP1025208A2
(en)
|
1997-10-20 |
2000-08-09 |
Universita' Degli Studi Di Padova |
A packaging cell line producing siv-pseudotyped mlv
|
|
FR2773561A1
(fr)
|
1998-01-15 |
1999-07-16 |
Centre Nat Rech Scient |
Utilisation d'une sequence riche en proline pour augmenter le caractere fusogenique d'enveloppes de retrovirus
|
|
US6451304B1
(en)
|
1998-03-09 |
2002-09-17 |
The Regents Of The University Of California |
Method for retrovirus vector production by separated gag and pol expression
|
|
JP2002512805A
(ja)
|
1998-04-29 |
2002-05-08 |
オクラホマ メディカル リサーチ ファウンデーション |
アデノウイルスベクターおよびレトロウイルスベクターからのレトロウイルスプロデューサー細胞の構築
|
|
US6291214B1
(en)
|
1998-05-11 |
2001-09-18 |
Glaxo Wellcome Inc. |
System for generating recombinant viruses
|
|
US7001733B1
(en)
|
1998-05-12 |
2006-02-21 |
Rigel Pharmaceuticals, Inc. |
Methods and compositions for screening for modulations of IgE synthesis, secretion and switch rearrangement
|
|
FR2778670B1
(fr)
|
1998-05-18 |
2002-12-13 |
Rhone Poulenc Rorer Sa |
Methodes et compositions pour la production de particules virales
|
|
GB9810752D0
(en)
|
1998-05-19 |
1998-07-15 |
Glaxo Group Ltd |
Cystosine deaminase gene
|
|
WO1999060110A2
(en)
|
1998-05-20 |
1999-11-25 |
The University Of Tennessee Research Corporation |
Stable envelope proteins for retroviral, viral and liposome vectors and use in gene and drug therapy
|
|
US6264940B1
(en)
|
1998-08-05 |
2001-07-24 |
The Research Foundation Of State University Of New York |
Recombinant poliovirus for the treatment of cancer
|
|
US6899871B2
(en)
|
1998-10-01 |
2005-05-31 |
University Of Southern California |
Gene delivery system and methods of use
|
|
DE69940521D1
(de)
|
1998-10-01 |
2009-04-16 |
Univ Southern California |
Retrovirales genübertragungssystem und entsprechendes verwendungverfahren
|
|
GB0122803D0
(en)
*
|
2001-09-21 |
2001-11-14 |
Oxford Biomedica Ltd |
Vector
|
|
US6576463B1
(en)
|
1999-01-15 |
2003-06-10 |
The Regents Of The University Of California |
Hybrid vectors for gene therapy
|
|
EP1173597A1
(en)
|
1999-04-29 |
2002-01-23 |
Aarhus University |
Expression of heterologous genes from an ires translational cassette in retroviral vectors
|
|
EP1059356B1
(en)
|
1999-06-09 |
2005-11-02 |
Universite Pierre Et Marie Curie Paris Vi |
Replicating retroviral constructs, preparation and uses for gene delivery
|
|
EP1059357A1
(en)
|
1999-06-09 |
2000-12-13 |
Universite Pierre Et Marie Curie Paris Vi |
Replicating or semi-replicating retroviral constructs, preparation and uses for gene delivery
|
|
WO2001004266A1
(en)
|
1999-07-08 |
2001-01-18 |
The Regents Of The Universty Of California |
A lung cancer associated retrovirus, gene delivery vector and methods of use thereof
|
|
WO2001040488A1
(en)
|
1999-11-30 |
2001-06-07 |
Novartis Ag |
Increased transgene expression in retroviral vectors having scaffold attachment region
|
|
US6322696B1
(en)
|
2000-02-25 |
2001-11-27 |
Gp Companies, Inc. |
Inlet filter for high pressure sprayer
|
|
US6692736B2
(en)
|
2000-03-24 |
2004-02-17 |
Cell Genesys, Inc. |
Cell-specific adenovirus vectors comprising an internal ribosome entry site
|
|
WO2002022663A2
(en)
|
2000-09-18 |
2002-03-21 |
Maxygen, Inc. |
Stress resistant retroviruses
|
|
GB0024550D0
(enExample)
|
2000-10-06 |
2000-11-22 |
Oxford Biomedica Ltd |
|
|
WO2002042482A2
(en)
|
2000-11-27 |
2002-05-30 |
Chiron Corporation |
Functional lentiviral vector from an mlv-based backbone
|
|
US7226779B2
(en)
|
2001-01-30 |
2007-06-05 |
The United States Of America As Represented By The Department Of Health And Human Services |
Hybrid adenoviral vector
|
|
DE10111433A1
(de)
|
2001-03-09 |
2002-09-19 |
Bundesrepublik Deutschland Let |
Replikationskompetente molekulare Klone von porcinem endogenem Retrovirus der Klasse A und Klasse B,abgeleitet von Schweine- und humanen Zellen
|
|
EP1379281A4
(en)
|
2001-03-26 |
2005-05-18 |
Univ Leland Stanford Junior |
HELPER-DEPENDENT ADENOVIRUS VECTOR SYSTEM AND METHOD FOR ITS USE
|
|
US7211247B2
(en)
|
2001-04-09 |
2007-05-01 |
University Of Southern California |
Lentivirus vectors for gene transfer to alveolar epithelial cells
|
|
JP2002335965A
(ja)
|
2001-05-14 |
2002-11-26 |
Japan Science & Technology Corp |
細胞特異的発現複製ベクター
|
|
DE10143237A1
(de)
|
2001-09-04 |
2003-03-20 |
Icon Genetics Ag |
Herstellung künstlicher interner ribosomaler Eingangsstellenelemente (Ires-Elemente)
|
|
JP2005510491A
(ja)
|
2001-10-26 |
2005-04-21 |
イミュノ−アールエックス， インコーポレイテッド |
免疫抑制を逆転させるための免疫治療
|
|
FR2832424B1
(fr)
|
2001-11-20 |
2004-09-24 |
Genethon Iii |
Plasmide chimere comprenant un genome retroviral replicatif et utilisations
|
|
US20030121068A1
(en)
|
2001-11-30 |
2003-06-26 |
Paul Orchard |
Vector encoding suicide and marker constructs
|
|
EP1470233A1
(en)
|
2002-02-01 |
2004-10-27 |
Transgene S.A. |
Adenoviral vectors for modulating the cellular activities associated with pods
|
|
US20060147420A1
(en)
|
2004-03-10 |
2006-07-06 |
Juan Fueyo |
Oncolytic adenovirus armed with therapeutic genes
|
|
EP1511767B1
(en)
|
2002-05-17 |
2009-07-22 |
RetroVec ApS |
A purified polypeptide, isolated nucleic acids encoding said polypeptide, vectors and use thereof
|
|
AU2003251931B2
(en)
|
2002-07-17 |
2008-03-06 |
Bristol-Myers Squibb Company |
Transgenic non-human mammals expressing a reporter nucleic acid under the regulation of androgen response elements
|
|
AU2003260769A1
(en)
|
2002-09-03 |
2004-03-29 |
Oxford Biomedica (Uk) Limited |
Retroviral vector and stable packaging cell lines
|
|
DE602004031341D1
(de)
|
2003-07-21 |
2011-03-24 |
Transgene Sa |
Multifunktionelle cytokine
|
|
US8106180B2
(en)
|
2003-08-07 |
2012-01-31 |
Whitehead Institute For Biomedical Research |
Methods and products for expression of micro RNAs
|
|
WO2005118802A2
(en)
|
2004-06-03 |
2005-12-15 |
The Regents Of The University Of California |
Targeting pseudotyped retroviral vectors
|
|
US20070003522A1
(en)
|
2004-07-08 |
2007-01-04 |
Albritton Lorraine M |
Methods and compositions for improved retroviral gene and drug delivery
|
|
AU2005300315A1
(en)
|
2004-11-04 |
2006-05-11 |
Pfizer Products Inc. |
CTLA-4 antibody and aromatase inhibitor or combination treatment for breast cancer
|
|
JP2008521405A
(ja)
|
2004-11-24 |
2008-06-26 |
ナノヴェクター・リミテッド |
ウイルスベクター
|
|
US20060147429A1
(en)
|
2004-12-30 |
2006-07-06 |
Paul Diamond |
Facilitated cellular reconstitution of organs and tissues
|
|
WO2006127980A2
(en)
|
2005-05-25 |
2006-11-30 |
The Regents Of The University Of California |
Optimized core promoters and uses therefor
|
|
JP2007054069A
(ja)
|
2005-08-24 |
2007-03-08 |
Medizinische Hochschule Hannover |
自己不活性化レトロウイルスベクター
|
|
AU2006296840A1
(en)
|
2005-09-30 |
2007-04-05 |
Zgene A/S |
Dekkera/Brettanomyces cytosine deaminases and their use
|
|
WO2007041350A2
(en)
|
2005-10-01 |
2007-04-12 |
Charles Stout |
Regulatable fusion promoters
|
|
US8034355B2
(en)
|
2005-10-07 |
2011-10-11 |
Presidents And Fellows Of Harvard College |
Attenuated nonsegmented negative-sense RNA viruses with reduced mRNA cap methyltransferase activity comprising mutations within conserved domain VI of the large polymerase
|
|
EP1795596A1
(en)
|
2005-12-08 |
2007-06-13 |
Ganymed Pharmaceuticals AG |
Composition and methods for therapy and diagnosis of cancer
|
|
EP2484782B1
(en)
|
2006-01-05 |
2015-11-18 |
The Ohio State University Research Foundation |
MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers
|
|
WO2007095201A2
(en)
|
2006-02-15 |
2007-08-23 |
The Regents Of The University Of California |
Pseudotyped retroviral vectors and methods of use thereof
|
|
WO2007107156A2
(en)
|
2006-03-17 |
2007-09-27 |
Aarhus Universitet |
Chimeric viral envelopes
|
|
JP5441685B2
(ja)
|
2006-05-02 |
2014-03-12 |
シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ |
チモシンα１の、単独またはＰＴＸ３またはガンシクロビルとの組合せにおける、サイトメガロウイルス感染の処置のための使用
|
|
WO2008011636A2
(en)
|
2006-07-21 |
2008-01-24 |
California Institute Of Technology |
Targeted gene delivery for dendritic cell vaccination
|
|
WO2008151633A2
(en)
|
2007-06-15 |
2008-12-18 |
Skau Aps |
Vectors for vaccines against lentivirus infections
|
|
EP2306823A4
(en)
|
2008-06-30 |
2012-09-26 |
Tocagen Inc |
5-FLUOROCYTOSINE FORMULATIONS AND USES THEREOF
|
|
DK2346995T3
(en)
|
2008-09-26 |
2019-02-11 |
Tocagen Inc |
GENETERIVE VECTORS AND CYTOSINDEAMINASES
|
|
US8829173B2
(en)
*
|
2008-09-26 |
2014-09-09 |
Tocagen Inc. |
Recombinant vectors
|
|
EP3546583A1
(en)
|
2009-06-17 |
2019-10-02 |
Tocagen Inc. |
Producer cells for replication competent retroviral vectors
|
|
CA2805941A1
(en)
*
|
2010-08-13 |
2012-02-16 |
Pioneer Hi-Bred International, Inc. |
Methods and compositions for targeting sequences of interest to the chloroplast
|
|
US9669049B2
(en)
|
2010-10-31 |
2017-06-06 |
Tocagen Inc. |
Compositions comprising gamma retrovirus vectors and methods of treating proliferative disorders
|
|
KR101888391B1
(ko)
|
2014-09-01 |
2018-08-14 |
삼성전자 주식회사 |
음성 신호 관리 방법 및 이를 제공하는 전자 장치
|